Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Antibody-Targeted Radionuclide Therapy

Andrew Scott

MD

🏢Olivia Newton-John Cancer Research Institute🌐Australia

Professor and Director

52
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Andrew Scott at the Olivia Newton-John Cancer Research Institute has contributed to radioimmunotherapy — combining antibodies or antibody fragments with cytotoxic radionuclides for targeted cancer therapy. His work on FAP-targeted radioligand therapies for the tumor stroma and on novel antibody-radionuclide conjugates for solid tumors addresses the challenge of delivering cytotoxic radiation selectively to heterogeneous cancer targets.

Share:

🧪Research Fields 研究领域

antibody radionuclide therapy
FAP targeted therapy
alpha emitter cancer
radio-immunotherapy
cancer nuclear medicine Australia

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Andrew Scott 的研究动态

Follow Andrew Scott's research updates

留下邮箱,当我们发布与 Andrew Scott(Olivia Newton-John Cancer Research Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment